Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14301-14350 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06773702
Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms
N/AActive, not recruiting
50 participants
Started: Mar 20, 2020 · Completed: Mar 20, 2025
1 condition1 sponsor1 location
NCT04326153
Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
30 participants
Started: Mar 20, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04705181
The Indications of First Molar Extraction at Tufts University, School of Dental Medicine
N/AActive, not recruiting
240 participants
Started: Mar 19, 2020 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT04302454
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
PHASE3Active, not recruiting
280 participants
Started: Mar 19, 2020 · Completed: Dec 1, 2027
1 condition2 sponsors13 locations
NCT06702540
Bio-reconfigurable Electronic Platform for Multiplex Detection of Viral Respiratory Pathogens
N/AActive, not recruiting
158 participants
Started: Mar 19, 2020 · Completed: Sep 28, 2025
1 condition3 sponsors1 location
NCT04229017
Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD
NAActive, not recruiting
236 participants
Started: Mar 18, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor17 locations
NCT04281667
Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery
PHASE4Active, not recruiting
604 participants
Started: Mar 18, 2020 · Completed: Oct 10, 2027
8 conditions1 sponsor3 locations
NCT04164082
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
PHASE2Active, not recruiting
161 participants
Started: Mar 18, 2020 · Completed: Mar 31, 2026
5 conditions1 sponsor391 locations
NCT04216719
Facilitating Opioid Care Connections
NAActive, not recruiting
3,440 participants
Started: Mar 18, 2020 · Completed: Apr 1, 2026
3 conditions7 sponsors1 location
NCT04181788
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
PHASE1/PHASE2Active, not recruiting
155 participants
Started: Mar 18, 2020 · Completed: Jun 9, 2026
2 conditions1 sponsor48 locations
NCT04179175
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
PHASE3Active, not recruiting
703 participants
Started: Mar 18, 2020 · Completed: Jul 15, 2026
1 condition1 sponsor191 locations
NCT04223141
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
NAActive, not recruiting
39 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04353687
Early Surgeon Experience With Robotic-Assisted Inguinal Hernia Repair
N/AActive, not recruiting
6 participants
Started: Mar 17, 2020 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT04354701
COVID-19 and Cancer Consortium Registry
N/AActive, not recruiting
19,275 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT03447509
Grasping Function After Spinal Cord Injury
NAActive, not recruiting
50 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04266912
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
PHASE1/PHASE2Active, not recruiting
23 participants
Started: Mar 17, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04251416
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
PHASE2Active, not recruiting
50 participants
Started: Mar 17, 2020 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT04280081
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
PHASE2Active, not recruiting
77 participants
Started: Mar 16, 2020 · Completed: Nov 30, 2027
2 conditions1 sponsor13 locations
NCT04175912
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
PHASE2Active, not recruiting
40 participants
Started: Mar 16, 2020 · Completed: Oct 31, 2025
15 conditions1 sponsor423 locations
NCT03831932
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Mar 16, 2020 · Completed: Mar 14, 2026
3 conditions1 sponsor11 locations
NCT06075368
Efficacy and Safety of GENOSS® SES in Patients with Acute Coronary Syndrome (GENOSS ACS)
N/AActive, not recruiting
757 participants
Started: Mar 16, 2020 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04109456
IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
PHASE1Active, not recruiting
120 participants
Started: Mar 16, 2020 · Completed: Dec 30, 2025
1 condition1 sponsor8 locations
NCT04190823
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors
PHASE1Active, not recruiting
63 participants
Started: Mar 15, 2020 · Completed: Dec 30, 2023
1 condition1 sponsor1 location
NCT04173949
Explorative Study for Treating Persistent Developmental Stuttering With Ramipril
PHASE3Active, not recruiting
10 participants
Started: Mar 15, 2020 · Completed: Dec 30, 2025
1 condition1 sponsor2 locations
NCT06311422
A 3-Year Clinical Evaluation Of Endocrown Restorations With Two Different Materials
NAActive, not recruiting
74 participants
Started: Mar 15, 2020 · Completed: Sep 15, 2028
1 condition1 sponsor1 location
NCT04922190
Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)
PHASE1Active, not recruiting
100 participants
Started: Mar 15, 2020 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06359340
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder
NAActive, not recruiting
440 participants
Started: Mar 13, 2020 · Completed: Oct 31, 2026
1 condition5 sponsors1 location
NCT04136171
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
PHASE3Active, not recruiting
1,438 participants
Started: Mar 13, 2020 · Completed: Aug 31, 2026
1 condition2 sponsors142 locations
NCT04266249
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
PHASE2Active, not recruiting
2,175 participants
Started: Mar 13, 2020 · Completed: Dec 31, 2038
9 conditions2 sponsors1008 locations
NCT04357275
The RIsk Stratification in COVID-19 Patients in the ICU Registry
N/AActive, not recruiting
10,000 participants
Started: Mar 13, 2020 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT04414280
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
N/AActive, not recruiting
1,150 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor18 locations
NCT04039347
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
PHASE3Active, not recruiting
262 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor37 locations
NCT03930498
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
PHASE2Active, not recruiting
68 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04180072
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
NAActive, not recruiting
51 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition9 sponsors7 locations
NCT04164264
Genetic Differences in Propofol Pharmacodynamics in Children
PHASE4Active, not recruiting
360 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04195945
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
PHASE2Active, not recruiting
60 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT04060758
Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
PHASE1Active, not recruiting
37 participants
Started: Mar 11, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor9 locations
NCT04987528
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
N/AActive, not recruiting
200 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04251130
Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI
N/AActive, not recruiting
150 participants
Started: Mar 11, 2020 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT04296162
Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)
PHASE2Active, not recruiting
178 participants
Started: Mar 10, 2020 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04142372
Tissue Microarray of Hematological Malignancies
N/AActive, not recruiting
5,000 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2026
1 condition5 sponsors1 location
NCT04622670
Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer
NAActive, not recruiting
40 participants
Started: Mar 10, 2020 · Completed: Jan 31, 2027
12 conditions2 sponsors1 location
NCT04481061
Engaging Adolescents in Decisions About Return of Genomic Research Results
NAActive, not recruiting
787 participants
Started: Mar 10, 2020 · Completed: Nov 30, 2026
6 conditions2 sponsors2 locations
NCT04787705
Multicenter Validation of a Predictor Model of ACHD Patients and Cardiac Surgery
N/AActive, not recruiting
547 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2025
2 conditions5 sponsors1 location
NCT04154943
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
PHASE2Active, not recruiting
79 participants
Started: Mar 10, 2020 · Completed: Nov 28, 2025
1 condition2 sponsors22 locations
NCT06920992
Cognitive Control Functions of the Human Thalamus
NAActive, not recruiting
184 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04244227
Pilot Research on Opioid Use Disorder
NAActive, not recruiting
10 participants
Started: Mar 10, 2020 · Completed: Feb 15, 2022
1 condition3 sponsors1 location
NCT04210687
Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis
NAActive, not recruiting
90 participants
Started: Mar 9, 2020 · Completed: May 30, 2028
1 condition1 sponsor1 location
NCT04227028
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC
PHASE1Active, not recruiting
5 participants
Started: Mar 9, 2020 · Completed: Apr 21, 2026
10 conditions2 sponsors6 locations
NCT04250155
An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
195 participants
Started: Mar 9, 2020 · Completed: Dec 15, 2025
1 condition1 sponsor29 locations